Market Summary
USD49.22-1.40
Market Closed-2.77%
ESTA Stock Price
ESTA RSI Chart
ESTA Valuation
ESTA Price/Sales (Trailing)
ESTA Profitability
ESTA Fundamentals
ESTA Revenue
ESTA Earnings
Price Action
52 Week Range
44.0379.88
(Low)(High)
Last 7 days
-5.4%
Last 30 days
-4.0%
Last 90 days
-22.3%
Trailing 12 Months
-13.4%
ESTA Financial Health
ESTA Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for ESTA
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-15 | LEWIN NICHOLAS SHERIDAN | bought | 22,452 | 56.13 | 400 | - |
2023-06-30 | Slotkin Bryan | acquired | 16,192 | 68.61 | 236 | - |
2023-06-30 | SCHUTTER EDWARD J | acquired | 18,730 | 68.61 | 273 | - |
2023-05-28 | LEWIN NICHOLAS SHERIDAN | acquired | - | - | 27,756 | - |
2023-05-24 | LEWIN NICHOLAS SHERIDAN | acquired | - | - | 2,324 | - |
2023-05-24 | Custin Ann | acquired | - | - | 2,324 | - |
2023-05-24 | Gillin Leslie | acquired | - | - | 2,324 | - |
2023-05-24 | SCHUTTER EDWARD J | acquired | - | - | 2,324 | - |
2023-05-24 | CONDON DENNIS E | acquired | - | - | 2,324 | - |
2023-05-24 | Slotkin Bryan | acquired | - | - | 2,324 | - |
Which funds bought or sold ESTA recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-08-24 | PERCEPTIVE ADVISORS LLC | reduced | -9.18 | -2,538,600 | 29,154,000 | 0.84% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -19.06 | -12,328 | 54,202 | -% |
2023-08-21 | Affinity Asset Advisors, LLC | added | 86.89 | 6,848,630 | 14,518,400 | 5.07% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -18.22 | -198,973 | 959,923 | -% |
2023-08-18 | Legato Capital Management LLC | added | 1.29 | 23,287 | 922,942 | 0.12% |
2023-08-16 | Nuveen Asset Management, LLC | added | 10.72 | 1,580,450 | 14,599,500 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | reduced | -2.83 | -1,168 | 68,176 | -% |
2023-08-15 | Belpointe Asset Management LLC | sold off | -100 | -13,819 | - | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | reduced | -17.86 | -510,155 | 2,526,430 | -% |
2023-08-14 | JANUS HENDERSON GROUP PLC | unchanged | - | 5,822 | 575,222 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Establishment Labs Holdings
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | pura vida investments, llc | 4.12% | 1,002,767 | SC 13G/A | |
| Feb 14, 2023 | rtw investments, lp | 9.8% | 2,374,138 | SC 13G/A | |
| Feb 14, 2023 | nantahala capital management, llc | 7.9% | 1,915,023 | SC 13G/A | |
| Feb 09, 2023 | brown advisory inc | 6% | 1,463,998 | SC 13G/A | |
| Jan 20, 2023 | chacon quiros juan jose | 5.8% | 1,401,132 | SC 13G/A | |
| Feb 14, 2022 | rtw investments, lp | 9.7% | 2,319,138 | SC 13G/A | |
| Feb 14, 2022 | nantahala capital management, llc | 8.8% | 2,123,236 | SC 13G/A | |
| Feb 14, 2022 | pura vida investments, llc | 5.50% | 1,319,398 | SC 13G/A | |
| Feb 07, 2022 | brown advisory inc | 6.95% | 1,668,969 | SC 13G/A | |
| Feb 01, 2022 | chacon quiros juan jose | 5.7% | 1,371,818 | SC 13G/A |
Recent SEC filings of Establishment Labs Holdings
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Aug 16, 2023 | 4 | Insider Trading | |
| Aug 09, 2023 | 10-Q | Quarterly Report | |
| Aug 08, 2023 | 8-K | Current Report | |
| Jul 05, 2023 | 4 | Insider Trading | |
| Jul 05, 2023 | 4 | Insider Trading |
Peers (Alternatives to Establishment Labs Holdings)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
SYK | 109.7B | 19.5B | 5.69% | 32.97% | 40.5 | 5.64 | 10.36% | 30.30% |
MDT | 108.4B | 31.6B | 1.36% | -7.86% | 29.89 | 3.44 | 1.57% | -30.40% |
ISRG | 102.6B | 6.7B | 4.79% | 48.19% | 71.98 | 15.39 | 11.75% | -0.66% |
BDX | 71.3B | 19.0B | -2.82% | 6.66% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 43.7B | 5.7B | -4.65% | -17.80% | 31.48 | 7.73 | 5.64% | -4.53% |
| MID-CAP | ||||||||
PEN | 10.1B | 937.8M | 4.57% | 35.10% | 345.25 | 10.72 | 16.30% | 250.21% |
SWAV | 7.5B | 616.6M | -5.28% | -28.68% | 30.68 | 12.13 | 69.52% | 343.68% |
GMED | 5.3B | 1.1B | -3.27% | -11.90% | 25.23 | 4.84 | 12.63% | 50.85% |
IRTC | 2.7B | 452.1M | -15.03% | -38.95% | -27.51 | 6.04 | 24.99% | 24.09% |
TNDM | 1.5B | 790.3M | -24.48% | -59.71% | -6.6 | 1.87 | 3.21% | -1604.53% |
| SMALL-CAP | ||||||||
AVNS | 952.1M | 780.7M | -7.16% | -11.41% | -26.45 | 1.22 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 620.2M | 162.9M | -22.73% | -61.80% | -11.73 | 3.81 | 42.67% | 12.82% |
BLFS | 551.7M | 162.2M | 18.78% | -45.96% | -6.56 | 3.4 | 9.71% | 12.37% |
Establishment Labs Holdings News
Returns for ESTA
Cumulative Returns on ESTA
16.4%
5-Year Cumulative Returns
40.2%
3-Year Cumulative Returns
Risks for ESTA
What is the probability of a big loss on ESTA?
95.8%
Probability that Establishment Labs Holdings stock will be more than 20% underwater in next one year
56.1%
Probability that Establishment Labs Holdings stock will be more than 30% underwater in next one year.
28.1%
Probability that Establishment Labs Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does ESTA drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Establishment Labs Holdings was unfortunately bought at previous high price.
Drawdowns
Financials for Establishment Labs Holdings
Income Statement (Last 12 Months)
| Income Statement (Last 12 Months) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 4.3% | 177,143,000 | 169,772,000 | 161,700,000 | 153,200,000 | 143,994,000 | 134,798,000 | 126,682,000 | 118,332,000 | 112,051,000 | 90,531,000 | 84,676,000 | 81,962,000 | 82,058,000 | 93,268,000 | 89,565,000 | 81,713,000 | 75,145,000 | 67,170,000 | 61,208,000 | 56,622,000 | 47,660,000 |
| Gross Profit | 2.5% | 114,545,000 | 111,738,000 | 106,595,000 | 102,656,000 | 96,236,000 | 90,250,000 | 85,404,000 | 75,822,000 | 71,348,000 | 57,114,000 | 52,502,000 | 54,217,000 | 53,309,000 | 59,087,000 | 54,861,000 | 48,375,000 | 44,250,000 | 39,455,000 | 36,118,000 | 32,808,000 | 26,299,000 |
| Operating Expenses | 4.0% | 160,095,000 | 153,981,000 | 146,253,000 | 138,520,000 | 130,627,000 | 118,869,000 | 110,544,000 | 99,613,000 | 88,686,000 | 79,421,000 | 80,418,000 | 78,521,000 | 83,787,000 | 89,345,000 | 85,802,000 | 83,532,000 | 76,688,000 | 68,827,000 | 59,982,000 | 52,639,000 | 46,055,000 |
| S&GA Expenses | 3.1% | 134,847,000 | 130,777,000 | 125,984,000 | 118,696,000 | 112,208,000 | 101,004,000 | 92,229,000 | 82,866,000 | 73,094,000 | 65,779,000 | 66,625,000 | 65,564,000 | 69,783,000 | 73,739,000 | 70,811,000 | 68,510,000 | 62,268,000 | 54,703,000 | 47,295,000 | 41,169,000 | 36,323,000 |
| R&D Expenses | 8.8% | 25,248,000 | 23,204,000 | 20,269,000 | 19,824,000 | 18,419,000 | 17,865,000 | 18,315,000 | 16,747,000 | 15,592,000 | 13,642,000 | 13,793,000 | 12,957,000 | 14,004,000 | 15,606,000 | 14,991,000 | 15,022,000 | 14,420,000 | 14,124,000 | 12,687,000 | 11,470,000 | 9,732,000 |
| EBITDA | 100.0% | - | -65,178,000 | -61,064,000 | -61,598,000 | -59,686,666 | -29,188,000 | -30,510,000 | -23,368,000 | -12,242,333 | -17,848,000 | -28,644,000 | -27,876,000 | -37,360,000 | -35,697,000 | -28,814,000 | - | - | - | - | - | - |
| EBITDA Margin | 100.0% | - | -0.38 | -0.38 | -0.40 | -0.41 | -0.22 | -0.24 | -0.20 | -0.11 | -0.20 | -0.34 | -0.34 | -0.46 | -0.38 | -0.32 | - | - | - | - | - | - |
| Interest Expenses | 1.8% | 13,456,000 | 13,224,000 | 11,760,000 | 11,886,000 | 10,299,000 | 9,159,000 | 9,062,000 | 8,947,000 | 9,540,000 | 9,422,000 | 9,373,000 | 9,290,000 | 8,209,000 | 8,600,000 | 8,696,000 | 8,834,000 | 9,233,000 | 8,885,000 | 8,814,000 | 8,336,000 | 12,823,000 |
| Earnings Before Taxes | 26.4% | -57,680,000 | -78,402,000 | -72,824,000 | -73,484,000 | -70,091,000 | -38,463,000 | -39,712,000 | -32,462,000 | -21,914,000 | -27,278,000 | -38,017,000 | -37,167,000 | -45,570,000 | -44,297,000 | -37,510,000 | -42,569,000 | -28,895,000 | -25,098,000 | -20,883,000 | -17,585,000 | -29,435,000 |
| EBT Margin | 100.0% | - | -0.46 | -0.45 | -0.48 | -0.49 | -0.29 | -0.31 | -0.27 | -0.20 | -0.30 | -0.45 | -0.45 | -0.56 | -0.47 | -0.42 | - | - | - | - | - | - |
| Net Income | 25.1% | -60,857,000 | -81,218,000 | -75,209,000 | -75,838,000 | -71,908,000 | -40,124,000 | -41,139,000 | -32,599,000 | -22,166,000 | -27,316,000 | -38,121,000 | -38,026,000 | -46,556,000 | -45,124,000 | -38,150,000 | -43,108,000 | -29,027,000 | -25,347,000 | -21,098,000 | -17,717,000 | -29,697,000 |
| Net Income Margin | 100.0% | - | -0.48 | -0.47 | -0.50 | -0.50 | -0.30 | -0.32 | -0.28 | -0.20 | -0.30 | -0.45 | -0.46 | -0.57 | -0.48 | -0.43 | - | - | - | - | - | - |
| Free Cashflow | 100.0% | - | -70,425,000 | -55,017,000 | -47,502,000 | -38,460,000 | -28,237,000 | -29,957,000 | -19,026,000 | -9,501,000 | -14,802,000 | -14,933,000 | -22,771,000 | -30,515,000 | -35,077,000 | -36,271,000 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 36.3% | 285 | 209 | 211 | 188 | 200 | 142 | 140 | 148 | 152 | 152 | 156 | 155 | 157 | 168 | 117 | 118 | 105 | 109 | 117 | 121 | 63.00 |
| Current Assets | 47.2% | 209 | 142 | 150 | 138 | 156 | 110 | 113 | 125 | 128 | 128 | 132 | 134 | 136 | 148 | 96.00 | 98.00 | 84.00 | 92.00 | 99.00 | 105 | 45.00 |
| Cash Equivalents | 110.5% | 90.00 | 43.00 | 66.00 | 65.00 | 91.00 | 45.00 | 53.00 | 65.00 | 77.00 | 78.00 | 85.00 | 81.00 | 86.00 | 94.00 | 38.00 | 43.00 | 32.00 | 43.00 | 53.00 | 66.00 | 12.00 |
| Inventory | 22.2% | 56.00 | 46.00 | 37.00 | 32.00 | 27.00 | 29.00 | 28.00 | 27.00 | 24.00 | 22.00 | 23.00 | 28.00 | 29.00 | 26.00 | 29.00 | 26.00 | 27.00 | 24.00 | 25.00 | 15.00 | 13.00 |
| Net PPE | 16.1% | 66.00 | 57.00 | 51.00 | 39.00 | 35.00 | 23.00 | 19.00 | 17.00 | 17.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 17.00 | 17.00 | 13.00 | 13.00 | 13.00 | 13.00 |
| Goodwill | 0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Liabilities | 2.3% | 230 | 225 | 219 | 186 | 184 | 94.00 | 89.00 | 87.00 | 83.00 | 80.00 | 81.00 | 75.00 | 75.00 | 78.00 | 77.00 | 74.00 | 51.00 | 48.00 | 47.00 | 44.00 | 61.00 |
| Current Liabilities | 4.3% | 43.00 | 41.00 | 39.00 | 32.00 | 35.00 | 37.00 | 32.00 | 30.00 | 27.00 | 25.00 | 26.00 | 20.00 | 21.00 | 22.00 | 23.00 | 20.00 | 21.00 | 17.00 | 16.00 | 15.00 | 19.00 |
| LT Debt, Non Current | 1.9% | 182 | 179 | 175 | - | - | 52.00 | 52.00 | 51.00 | 51.00 | 50.00 | 50.00 | 49.00 | 49.00 | - | 48.00 | - | - | - | - | - | - |
| Shareholder's Equity | 443.0% | 55.00 | -16.00 | -8.18 | 2.00 | 16.00 | 48.00 | 51.00 | 62.00 | 69.00 | 73.00 | 75.00 | 80.00 | 82.00 | 90.00 | 40.00 | 44.00 | 54.00 | 61.00 | 69.00 | 77.00 | 2.00 |
| Retained Earnings | -5.7% | -310 | -293 | -281 | -268 | -249 | -212 | -206 | -192 | -177 | -172 | -165 | -159 | -155 | -144 | -127 | -121 | -108 | -99.75 | -88.97 | -78.46 | -79.77 |
| Additional Paid-In Capital | 6.2% | 56.00 | 53.00 | 50.00 | 47.00 | 44.00 | 40.00 | 37.00 | 34.00 | 31.00 | 28.00 | 27.00 | 26.00 | 24.00 | 23.00 | 21.00 | 20.00 | 19.00 | 17.00 | 15.00 | 13.00 | 30.00 |
| Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.00 | 6.00 | 5.00 | 5.00 | 4.00 |
| Shares Outstanding | 5.4% | 26.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 23.00 | 22.00 | 21.00 | 20.00 | 20.00 | 20.00 | 20.00 | 19.00 | 15.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -24.9% | -84.85 | -67.94 | -52.17 | -45.86 | -36.33 | -25.82 | -27.53 | -16.39 | -6.98 | -12.26 | -12.51 | -19.97 | -27.82 | -28.79 | -29.98 | -34.44 | -34.04 | -35.95 | -33.88 | -33.55 | -32.08 |
| Share Based Compensation | -1.3% | 13.00 | 13.00 | - | 13.00 | 14.00 | 12.00 | - | 10.00 | 8.00 | 6.00 | - | 6.00 | 6.00 | 6.00 | - | 6.00 | 7.00 | - | - | - | - |
| Cashflow From Investing | 14.3% | -28.56 | -33.33 | -34.79 | -27.98 | -24.25 | -11.37 | -7.16 | -4.67 | -5.74 | -6.14 | -5.56 | -5.79 | -4.38 | -7.26 | -7.77 | -10.84 | -10.66 | -6.77 | -5.73 | -0.85 | -0.66 |
| Cashflow From Financing | 12.2% | 112 | 100 | 100 | 75.00 | 76.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 65.00 | 64.00 | 87.00 | 87.00 | 23.00 | 22.00 | 65.00 | 80.00 | 82.00 | 95.00 | 43.00 |
| Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.00 |
ESTA Income Statement
2023-06-30Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenue | $ 48,561 | $ 41,190 | $ 95,085 | $ 79,642 |
| Cost of revenue | 18,300 | 13,736 | 34,745 | 27,252 |
| Gross profit | 30,261 | 27,454 | 60,340 | 52,390 |
| Operating expenses: | ||||
| Sales, general and administrative | 37,027 | 32,957 | 68,733 | 59,870 |
| Research and development | 6,947 | 4,903 | 13,480 | 8,501 |
| Total operating expenses | 43,974 | 37,860 | 82,213 | 68,371 |
| Loss from operations | (13,713) | (10,406) | (21,873) | (15,981) |
| Interest income | 170 | 32 | 245 | 52 |
| Interest expense | (3,620) | (3,388) | (7,376) | (5,680) |
| Change in fair value of derivative instruments | 0 | 1,099 | 0 | 703 |
| Other income (expense), net | 1,343 | (4,860) | 2,072 | (2,151) |
| Loss on extinguishment of debt | 0 | (19,019) | 0 | (19,019) |
| Loss before income taxes | (15,820) | (36,542) | (26,932) | (42,076) |
| Provision for income taxes | (925) | (564) | (1,755) | (963) |
| Net loss | $ (16,745) | $ (37,106) | $ (28,687) | $ (43,039) |
| Basic net loss per share (in dollars per share) | $ (0.65) | $ (1.52) | $ (1.14) | $ (1.77) |
| Diluted net loss per share (in dollars per share) | $ (0.65) | $ (1.52) | $ (1.14) | $ (1.77) |
| Weighted average outstanding shares used for basic net loss per share (in shares) | 25,615,444 | 24,396,847 | 25,144,375 | 24,354,005 |
| Weighted average outstanding shares used for diluted net loss per share (in shares) | 25,615,444 | 24,396,847 | 25,144,375 | 24,354,005 |
ESTA Balance Sheet
2023-06-30Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash | $ 90,182 | $ 66,355 |
| Accounts receivable, net of allowance for doubtful accounts of $1,223 and $741 | 51,395 | 35,423 |
| Inventory, net | 56,370 | 36,583 |
| Prepaid expenses and other current assets | 11,070 | 11,543 |
| Total current assets | 209,017 | 149,904 |
| Long-term assets: | ||
| Property and equipment, net of accumulated depreciation | 66,208 | 51,092 |
| Goodwill | 465 | 465 |
| Intangible assets, net of accumulated amortization | 4,229 | 4,608 |
| Right-of-use operating lease assets, net | 3,811 | 3,702 |
| Other non-current assets | 1,569 | 1,290 |
| Total assets | 285,299 | 211,061 |
| Current liabilities: | ||
| Accounts payable | 24,359 | 20,034 |
| Accrued liabilities | 17,434 | 17,237 |
| Other liabilities, short-term | 1,480 | 1,688 |
| Total current liabilities | 43,273 | 38,959 |
| Long-term liabilities: | ||
| Note payable, net of debt discount and issuance costs | 181,970 | 175,461 |
| Operating lease liabilities, non-current | 3,191 | 3,200 |
| Other liabilities, long-term | 1,992 | 1,626 |
| Total liabilities | 230,426 | 219,246 |
| Commitments and contingencies (Note 12) | ||
| Shareholders’ equity (deficit): | ||
| Common shares - zero par value, unlimited amount authorized; 26,181,033 and 24,815,908 shares issued at June 30, 2023 and December 31, 2022, respectively; 25,772,963 and 24,407,838 shares outstanding at June 30, 2023 and December 31, 2022, respectively | 309,725 | 223,637 |
| Additional paid-in-capital | 56,473 | 49,911 |
| Treasury shares, at cost, 408,070 shares held at June 30, 2023 and December 31, 2022 | (2,854) | (2,854) |
| Accumulated deficit | (310,281) | (281,594) |
| Accumulated other comprehensive income | 1,810 | 2,715 |
| Total shareholders’ equity (deficit) | 54,873 | (8,185) |
| Total liabilities and shareholders’ equity (deficit) | $ 285,299 | $ 211,061 |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.